Bone age at discontinuation of medroxyprogesterone acetate therapy in girls with precocious puberty: effect on final height.

To determine the final height of patients with precocious pubery treated with medroxyprogesterone acetate (MPA; 150 mg every week) for a period > 1 year (mean ± SD = 3.24 ± 1.85 years), data from a gr